Related Experiment Video

Updated: May 31, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.0K

Two Cysteines in Raf Kinase Inhibitor Protein Make Differential Contributions to Structural Dynamics In Vitro

Hyun Sang Cho1, Mohammad Faysal Al Mazid2, Eun-Young Lee1

  • 1Cancer Microenvironment Branch, Division of Cancer Biology, Research Institute, National Cancer Center, Goyang-si 10408, Republic of Korea.

Molecules (Basel, Switzerland)
|January 25, 2025
PubMed

Insights

Raf kinase binding protein (RKIP) structural dynamics, specifically cysteine 133, influence its monomer-dimer switch. This dimerization switch is crucial for regulating RKIP

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Raf kinase binding protein (RKIP) is a scaffolding protein regulating key cellular pathways like the Raf-MEK-ERK cascade.
  • RKIP acts as a negative regulator, making it a potential therapeutic target for cancer.
  • The mechanism behind RKIP's transition between monomeric and dimeric forms, and its impact on binding partners, remains unclear.

Purpose of the Study:

  • To elucidate the role of cysteine 133 in the structural dynamics and dimerization of recombinant human RKIP (rhRKIP).
  • To investigate the potential of targeting RKIP dimerization for cancer therapy.

Main Methods:

  • Purification of recombinant human RKIP (rhRKIP) from Escherichia coli.
  • Site-directed mutagenesis of cysteine 133 to alanine or serine.
  • Dynamic light scattering and liquid chromatography (LC) quadrupole time-of-flight (Q-TOF) mass spectrometry (MS) for structural analysis.
  • LC-MS/MS for peptide identification.
  • Assessment of cancer cell viability upon treatment with RKIP-mimicking peptides.

Main Results:

  • Mutation of cysteine 133 did not alter biochemical characteristics but influenced solution behavior.
  • Dynamic light scattering and LC-MS/MS confirmed the role of cysteine 133 in rhRKIP dimerization.
  • A 32-amino acid peptide mimicking the dimerization interface abrogated rhRKIP dimer formation.
  • The peptide and its derivatives showed effects on cancer cell viability.

Conclusions:

  • Cysteine 133 is critical for regulating RKIP structural dynamics and dimerization.
  • Controlling RKIP dimerization, potentially with reducing agents or specific peptides, could offer a novel strategy for targeting cancer cells.
Keywords:
Raf kinase inhibitor proteincancercysteinedimerization

More Related Videos

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

934
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Related Concept Videos

Protein Dynamics in Living Cells01:19

Protein Dynamics in Living Cells

Different fluorescence-based techniques are used to study the protein dynamics in living cells. These techniques include FRAP, FRET, and PET.
Fluorescent recovery after photobleaching (FRAP) is a fluorescent-protein-based detection technique used to quantify protein movement rates within the cell. This method exposes a small portion of the cell to an intense laser beam. The laser beam causes permanent photobleaching of the fluorophore-tagged proteins in the exposed region. As the bleached...
2.1K